Artificial intelligence for drug discovery: Resources, methods, and applications

W Chen, X Liu, S Zhang, S Chen - Molecular therapy Nucleic acids, 2023 - cell.com
Conventional wet laboratory testing, validations, and synthetic procedures are costly and
time-consuming for drug discovery. Advancements in artificial intelligence (AI) techniques …

Neural multi-task learning in drug design

S Allenspach, JA Hiss, G Schneider - Nature Machine Intelligence, 2024 - nature.com
Multi-task learning (MTL) is a machine learning paradigm that aims to enhance the
generalization of predictive models by leveraging shared information across multiple tasks …

Interpretable bilinear attention network with domain adaptation improves drug–target prediction

P Bai, F Miljković, B John, H Lu - Nature Machine Intelligence, 2023 - nature.com
Predicting drug–target interaction is key for drug discovery. Recent deep learning-based
methods show promising performance, but two challenges remain: how to explicitly model …

Learning functional properties of proteins with language models

S Unsal, H Atas, M Albayrak, K Turhan… - Nature Machine …, 2022 - nature.com
Data-centric approaches have been used to develop predictive methods for elucidating
uncharacterized properties of proteins; however, studies indicate that these methods should …

AttentionMGT-DTA: A multi-modal drug-target affinity prediction using graph transformer and attention mechanism

H Wu, J Liu, T Jiang, Q Zou, S Qi, Z Cui, P Tiwari… - Neural Networks, 2024 - Elsevier
The accurate prediction of drug-target affinity (DTA) is a crucial step in drug discovery and
design. Traditional experiments are very expensive and time-consuming. Recently, deep …

[HTML][HTML] Chemical language models for de novo drug design: Challenges and opportunities

F Grisoni - Current Opinion in Structural Biology, 2023 - Elsevier
Generative deep learning is accelerating de novo drug design, by allowing the generation of
molecules with desired properties on demand. Chemical language models–which generate …

MolTrans: molecular interaction transformer for drug–target interaction prediction

K Huang, C **ao, LM Glass, J Sun - Bioinformatics, 2021 - academic.oup.com
Motivation Drug–target interaction (DTI) prediction is a foundational task for in-silico drug
discovery, which is costly and time-consuming due to the need of experimental search over …

Deep learning in virtual screening: recent applications and developments

TB Kimber, Y Chen, A Volkamer - International journal of molecular …, 2021 - mdpi.com
Drug discovery is a cost and time-intensive process that is often assisted by computational
methods, such as virtual screening, to speed up and guide the design of new compounds …

Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities

A Gangwal, A Ansari, I Ahmad, AK Azad… - Frontiers in …, 2024 - frontiersin.org
There are two main ways to discover or design small drug molecules. The first involves fine-
tuning existing molecules or commercially successful drugs through quantitative structure …

DeepDTAF: a deep learning method to predict protein–ligand binding affinity

K Wang, R Zhou, Y Li, M Li - Briefings in Bioinformatics, 2021 - academic.oup.com
Biomolecular recognition between ligand and protein plays an essential role in drug
discovery and development. However, it is extremely time and resource consuming to …